Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom | Zendy

N. Woodford | Zendy; Jian Zhang | Zendy; M. Warner | Zendy; Mary E. Kaufmann | Zendy; J. Matos | Zendy; A. MacDonald | Zendy; Daniel Brudney | Zendy; D Sompolinsky | Zendy; Shiri NavonVenezia | Zendy; David M. Livermore | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom

Author(s) -

N. Woodford,

Jian Zhang,

M. Warner,

Mary E. Kaufmann,

J. Matos,

A. MacDonald,

Daniel Brudney,

D Sompolinsky,

Shiri NavonVenezia,

David M. Livermore

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn396

Subject(s) - amikacin , microbiology and biotechnology , klebsiella pneumoniae , colistin , imipenem , tigecycline , pulsed field gel electrophoresis , biology , fosfomycin , agar dilution , gentamicin , virology , antibiotic resistance , antibiotics , genotype , minimum inhibitory concentration , escherichia coli , genetics , gene

KPC-type carbapenemases are increasingly prevalent in parts of the USA and Israel and are an emerging concern in South America, Europe and China. We investigated the UK's first two KPC-producing Klebsiella pneumoniae isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research